Efficacy of thyroxine treatment in women with reproductive disorders and hyperprolactinemia developed on the background of primary hypothyroidism and correlations between prolactin and thyroid hormones

Khatuna Sokhadze, Sophio Kvaliashvili, Jenaro Kristesashvili



Background: Determination of the efficacy of treatment of hyperprolactinemia developed on the background of primary hypothyroidism in women with reproductive disorders is of great medical importance.

Aim: To determine effectiveness of performed treatment with thyroxine in women with hyperprolactinemia developed on the background of primary hypothyroidism and determination of correlations between prolactin and other hormones before and after treatment in women with hyperprolactinemia developed on the background of primary hypothyroidism.  

Methods: Prospective cohort study was conducted at the Center for Reproductive Medicine "Universe" and the clinic ‘’Medhealth’’ during 2016-2018. Study involved 52 untreated women with hyperprolactinemia developed on the background of primary hypothyroidism. Medical history was analyzed with each of them. Objective investigations were conducted. Prolactin (PRL), thyroid stimulating hormone (TSH), free thyroxine (FT4), anti–thyroid peroxidase (anti-TPO), follicle stimulating hormone(FSH), luteinizing hormone (LH), estradiol (E2), total testosterone (TT), free testosterone (FT) and progesterone were studied in blood serum in dynamics with immunoassay analysis (ELISA) method. Ultrasound examination of pelvic organs and thyroid gland was performed. In all cases, L-thyroxine was used continuously to treat hyperprolactinemia with dose adjustment in dynamics. In patients with whom despite stable compensation of hypothyroidism, prolactin levels were not normalized, dopamine agonist (bromocriptine) was included in the treatment along with continued thyroxine administration.

Results:The mean levels of PRL and TSH before treatment were significantly high compared to the reference indicators (p<0.05). Anti-TPO mean levels (p <0.05) were also significantly high compared to the reference rates, while the E2 and progesterone mean levels were significantly lower (p <0.05). Prior to treatment, there was no significant difference between mean FT4, FSH, LH, TT, FT and reference rates (p> 0.05). After the treatment PRL, TSH, and anti-TPO significantly reduced;  E2, progesteron significantly increased; FT4, FSH, LH, TT, FT remained within reference rates.

Conclusions: Continuous treatment with thyroxine normalized prolactin levels, regulated the menstrual cycle and restored ovulation in patients with mild hyperprolactinemia developed on the  background of primary hypothyroidism, which accounted for 88.9% of the women involved in the study. Despite stable compensation of hypothyroidism achieved with thyroxine replacement therapy, no normalization of prolactin levels was observed in 11.1% of patients with moderate hyperprolactinemia developed on the background of primary hypothyroidism and a dopamine agonist was included in the treatment, after which the prolactin level normalized, menstrual cycle regulated and ovulation restored. Prior to treatment, significant positive correlation of prolactin with TSH and significant negative correlation with E2 and Progesterone was detected in women with hyperprolactinemia developed on the background of primary hypothyroidism. Significant correlation of prolactin with FT4, anti-TPO, FSH, LH, TT and FT was not detected. After the treatment significant correlation was determined only between prolactin and TSH.


Hypothyroidism, Hyperprolactinaemia, Fertility disorders.

Full Text:



Majumdar A, Sharma MN. Hyperprolactinemia. J Hum Reprod Sci 2013; 6: 168–175.

Sharma LK, Sharma N, Gadpayle AK, Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. European journal of internal medicine. 2016 Nov 1;35:106-110.

Bahar A, Akha O, Kashi Z, Vesgari Z. Hyperprolactinemia in association with subclinical hypothyroidism. Caspian journal of internal medicine. 2011;2(2):229-233.

Ul Ain N, Rehman HA, Abdullah FE. Correlation of prolactin and thyroid hormone levels in infertile women: a cross-sectional study in Pakistan. J Clin Exp Pathol.2017;7(304):2161-2164.

Khorassanizadeh R, Sundaresh V, Levine SN. Primary Hypothyroidism with Exceptionally High Prolactin—A Really Big Deal. World neurosurgery. 2016 Jul 1;91:675-679.

Dittrich R, Beckmann MW, Oppelt PG, Hoffmann I, Lotz L, Kuwert T, Mueller A. Thyroid hormone receptors and reproduction. Journal of reproductive immunology.2011 Jun 1;90(1): 58-66.

Aziz K, Shahbaz A, Umair M, Sharifzadeh M, Sachmechi I. Hyperprolactinemia with Galactorrhea Due to Subclinical Hypothyroidism: A Case Report and Review of Literature. Cureus. 2018 May;10(5).1-6.

Hekimsoy Z, Kafesçiler S, Güçlü F, Özmen B. The prevalence of hyperprolactinaemia in overt andsubclinical hypothyroidism. Endocrine journal. 2010; 57(12): 1011-1015.

Goel P, KahKaSha SN, GuPta BK, Goel K. Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism. Journal of clinical and diagnostic research: JCDR. 2015 Jan;9(1):BC15.

Hivre MD, Bhale DV, Mahat RK, Bujurge AA. Study of serum TSH and prolactin levels in patients of female infertility. Int J Rec Tre Sci Tech. 2013;9:144-145.

Araujo B, Belo S, Carvalho D. Pregnancy and tumor outcomes in women with prolactinoma. Experimental and Clinical Endocrinology & Diabetes. 2017 Nov;125(10):642-648.

Molitch ME. Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. European journal of endocrinology. 2015 May 1;172(5):R205-213.

Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2011 Feb 1;96(2):273-288.

Turankar S, Sonone K, Turankar A. Hyperprolactinaemia and its comparision with hypothyroidism in primary infertile women. Journal of clinical and diagnostic research: JCDR. 2013 May;7(5):794-796.

Bassey IE, Udoh AE, Essien OE, Isong IK, Gali RM, Archibong EE. Thyroid hormones and prolactin levels in infertile women in southern Nigeria. Journal of clinical and diagnostic research: JCDR. 2015 Mar;9(3):OC13.

Tasneem A, Fatima I, Ali A, Mehmood N, Amin MK. The incidence of hyperprolactinaemia and associated hypothyroidism: local experience from Lahore. Pak J Nuclear Med. 2011;1:49-55.

Dedov II, Melnichenko GA, Romantsova TI. Hyper prolactinemia syndrome. Tver. Triad. 2004; 152.

Силагадзе М. Первичный гипотиреоз и репродуктивная функция женщины.2001. Тбилиси; 5-41.

KeRW. Endocrine basis for recurrent pregnancy loss. Obstetrics and Gynecology Clinics. 2014 Mar 1;41(1):103-112.

Fupare S, Gadhiya BM, Jambhulkar RK, Tale A. Correlation of thyroid hormones with FSH, LH and Prolactin in infertility in the reproductive age group women. Age. 2015;23(2.48):216-222.

Amrane S, McConnell R. Endocrine causes of recurrent pregnancy loss. In Seminars in perinatology 2019 Mar 1 (Vol. 43, No.2, pp. 80-83).


  • There are currently no refbacks.


Become a REVIEWER 


ISSN: 2346-8491 (online)